|
Mao, Jun J |
Sloan-Kettering Inst Can Research |
Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Hill, Deirdre |
University Of New Mexico Health Scis Ctr |
Chronic Kidney Disease Development in Cancer Treatment and Survival |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Lee, Richard T |
Beckman Research Institute/City Of Hope |
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Grueber, Wesley B |
Columbia University Health Sciences |
Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy |
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Valdimarsdottir, Heiddis |
Icahn School Of Medicine At Mount Sinai |
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Hu, Jim |
Weill Medical Coll Of Cornell Univ |
Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL) |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Rini, Christine |
Northwestern University At Chicago |
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Ross, Stephen |
New York University School Of Medicine |
Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Sohl, Stephanie Jean |
Wake Forest University Health Sciences |
REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) |
PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program |
|
Prigerson, Holly Gwen |
Weill Medical Coll Of Cornell Univ |
Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) |
PAR-21-333: NCI Outstanding Investigator Award |
|
Grace, Peter |
University Of Tx Md Anderson Can Ctr |
PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain |
RFA-CA-17-017: Research Answers to NCI's Provocative Questions |
|
Mohile, Supriya G |
University Of Rochester |
Understanding Treatment Tolerability in Older Patients with Cancer |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
|
Basch, Ethan M. |
Univ Of North Carolina Chapel Hill |
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
|
Gray, Robert J |
Dana-Farber Cancer Inst |
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
|
Tighiouart, Mourad |
Cedars-Sinai Medical Center |
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials |
RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
